Literature DB >> 19805648

Activin A and follistatin-like 3 determine the susceptibility of heart to ischemic injury.

Yuichi Oshima1, Noriyuki Ouchi, Masayuki Shimano, David R Pimentel, Kyriakos N Papanicolaou, Kalyani D Panse, Kunihiro Tsuchida, Enrique Lara-Pezzi, Se-Jin Lee, Kenneth Walsh.   

Abstract

BACKGROUND: Transforming growth factor-beta family cytokines have diverse actions in the maintenance of cardiac homeostasis. Activin A is a member of this family whose regulation and function in heart are not well understood at a molecular level. Follistatin-like 3 (Fstl3) is an extracellular regulator of activin A protein, and its function in the heart is also unknown. METHODS AND
RESULTS: We analyzed the expression of various transforming growth factor-beta superfamily cytokines and their binding partners in mouse heart. Activin betaA and Fstl3 were upregulated in models of myocardial injury. Overexpression of activin A with an adenoviral vector (Ad-actbetaA) or treatment with recombinant activin A protein protected cultured myocytes from hypoxia/reoxygenation-induced apoptosis. Systemic overexpression of activin A in mice by intravenous injection of Ad-actbetaA protected hearts from ischemia/reperfusion injury. Activin A induced the expression of Bcl-2, and ablation of Bcl-2 by small interfering RNA abrogated its protective action in myocytes. The protective effect of activin A on cultured myocytes was abolished by treatment with Fstl3 or by a pharmacological activin receptor-like kinase inhibitor. Cardiac-specific Fstl3 knockout mice showed significantly smaller infarcts after ischemia/reperfusion injury that was accompanied by reduced apoptosis.
CONCLUSIONS: Activin A and Fstl3 are induced in heart by myocardial stress. Activin A protects myocytes from death, and this activity is antagonized by Fstl3. Thus, the relative expression levels of these factors after injury is a determinant of cell survival in the heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805648      PMCID: PMC2764796          DOI: 10.1161/CIRCULATIONAHA.109.872200

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Elevated levels of activin A in heart failure: potential role in myocardial remodeling.

Authors:  Arne Yndestad; Thor Ueland; Erik Øie; Geir Florholmen; Bente Halvorsen; Håvard Attramadal; Svein Simonsen; Stig S Frøland; Lars Gullestad; Geir Christensen; Jan Kristian Damås; Pål Aukrust
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690

3.  Expression of follistatin-related genes is altered in heart failure.

Authors:  Enrique Lara-Pezzi; Leanne E Felkin; Emma J Birks; Padmini Sarathchandra; Kalyani D Panse; Robert George; Jennifer L Hall; Magdi H Yacoub; Nadia Rosenthal; Paul J R Barton
Journal:  Endocrinology       Date:  2008-07-10       Impact factor: 4.736

4.  TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

Authors:  Jo El J Schultz; Sandra A Witt; Betty J Glascock; Michelle L Nieman; Peter J Reiser; Stacey L Nix; Thomas R Kimball; Thomas Doetschman
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis.

Authors:  M Wankell; B Munz; G Hübner; W Hans; E Wolf; A Goppelt; S Werner
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

6.  Induction of cachexia in mice by systemically administered myostatin.

Authors:  Teresa A Zimmers; Monique V Davies; Leonidas G Koniaris; Paul Haynes; Aurora F Esquela; Kathy N Tomkinson; Alexandra C McPherron; Neil M Wolfman; Se-Jin Lee
Journal:  Science       Date:  2002-05-24       Impact factor: 47.728

7.  Activin/TGF-beta induce apoptosis through Smad-dependent expression of the lipid phosphatase SHIP.

Authors:  Hector Valderrama-Carvajal; Eftihia Cocolakis; Annie Lacerte; Eun-Hye Lee; Gerald Krystal; Suhad Ali; Jean-Jacques Lebrun
Journal:  Nat Cell Biol       Date:  2002-12       Impact factor: 28.824

8.  Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis.

Authors:  T Vänttinen; J Liu; T Kuulasmaa; P Kivinen; R Voutilainen
Journal:  J Endocrinol       Date:  2003-09       Impact factor: 4.286

9.  Bcl-2 overexpression corrects mitochondrial defects and ameliorates inherited desmin null cardiomyopathy.

Authors:  Noah Weisleder; George E Taffet; Yassemi Capetanaki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-08       Impact factor: 11.205

10.  Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism.

Authors:  Noriyuki Ouchi; Yuichi Oshima; Koji Ohashi; Akiko Higuchi; Chiaki Ikegami; Yasuhiro Izumiya; Kenneth Walsh
Journal:  J Biol Chem       Date:  2008-08-20       Impact factor: 5.157

View more
  34 in total

Review 1.  The cardiokine story unfolds: ischemic stress-induced protein secretion in the heart.

Authors:  Shirin Doroudgar; Christopher C Glembotski
Journal:  Trends Mol Med       Date:  2011-02-01       Impact factor: 11.951

2.  The TGF-β pathway mediates doxorubicin effects on cardiac endothelial cells.

Authors:  Zuyue Sun; Jill Schriewer; Mingxin Tang; Jerry Marlin; Frederick Taylor; Ralph V Shohet; Eugene A Konorev
Journal:  J Mol Cell Cardiol       Date:  2015-12-11       Impact factor: 5.000

Review 3.  Functions for the cardiomyokine, MANF, in cardioprotection, hypertrophy and heart failure.

Authors:  Christopher C Glembotski
Journal:  J Mol Cell Cardiol       Date:  2010-10-21       Impact factor: 5.000

Review 4.  Cardiac muscle regeneration: lessons from development.

Authors:  Mark Mercola; Pilar Ruiz-Lozano; Michael D Schneider
Journal:  Genes Dev       Date:  2011-02-15       Impact factor: 11.361

5.  Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload.

Authors:  Masayuki Shimano; Noriyuki Ouchi; Kazuto Nakamura; Bram van Wijk; Koji Ohashi; Yasuhide Asaumi; Akiko Higuchi; David R Pimentel; Flora Sam; Toyoaki Murohara; Maurice J B van den Hoff; Kenneth Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-10       Impact factor: 11.205

6.  Activin A Predicts Left Ventricular Remodeling and Mortality in Patients with ST-Elevation Myocardial Infarction.

Authors:  Jeng-Feng Lin; Shun-Yi Hsu; Ming-Sheng Teng; Semon Wu; Chien-An Hsieh; Shih-Jung Jang; Chih-Jen Liu; Hsuan-Li Huang; Yu-Lin Ko
Journal:  Acta Cardiol Sin       Date:  2016-07       Impact factor: 2.672

7.  Preserved heart function and maintained response to cardiac stresses in a genetic model of cardiomyocyte-targeted deficiency of cyclooxygenase-2.

Authors:  Kyriakos N Papanicolaou; John M Streicher; Tomo-O Ishikawa; Harvey Herschman; Yibin Wang; Kenneth Walsh
Journal:  J Mol Cell Cardiol       Date:  2010-04-24       Impact factor: 5.000

Review 8.  Cardiomyokines from the heart.

Authors:  Ayano Chiba; Haruko Watanabe-Takano; Takahiro Miyazaki; Naoki Mochizuki
Journal:  Cell Mol Life Sci       Date:  2017-12-13       Impact factor: 9.261

9.  Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism.

Authors:  Sonomi Maruyama; Rei Shibata; Ryosuke Kikuchi; Yasuhiro Izumiya; Taku Rokutanda; Satoshi Araki; Yoshiyuki Kataoka; Koji Ohashi; Hiroyuki Daida; Shinji Kihara; Hisao Ogawa; Toyoaki Murohara; Noriyuki Ouchi
Journal:  J Biol Chem       Date:  2011-11-11       Impact factor: 5.157

10.  Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes.

Authors:  Kalyani D Panse; Leanne E Felkin; Marina M López-Olañeta; Jesús Gómez-Salinero; María Villalba; Lucía Muñoz; Kazuto Nakamura; Masayuki Shimano; Kenneth Walsh; Paul J R Barton; Nadia Rosenthal; Enrique Lara-Pezzi
Journal:  J Cardiovasc Transl Res       Date:  2012-08-23       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.